The Extrinsic Pathway of Coagulation

Overview

Fig. 46.2 - Miller's Anesthesia, 10e: TF-dependent initiation of coagulation at vascular injury site, showing progression from initiation through propagation to fibrin stabilization.

Step-by-Step Mechanism

1. Trigger: Tissue Factor Exposure

• Under normal conditions, the vascular endothelium prevents contact between TF (abundant in subendothelial tissues) and circulating coagulation factors.
• Vascular injury disrupts this barrier, exposing TF to blood within seconds.

2. TF-FVIIa Complex Formation

• A small amount of Factor VII circulates constitutively in plasma in its active form (FVIIa).
• Exposed TF rapidly binds FVIIa, forming the TF-FVIIa complex (also called the "extrinsic tenase").
• This complex is anchored to the phospholipid cell membrane and requires Ca2+ for full activity.
• FVII can also be activated proteolytically by thrombin or other serine proteases, and FVIIa-TF can be activated via cross-talk with FXIIa.

3. Activation of Factor X (and Factor IX)

• The TF-FVIIa complex activates Factor X → FXa by proteolysis (this is the key step feeding into the common pathway).
• Critically, the TF-FVIIa complex also activates Factor IX of the intrinsic pathway - demonstrating that the extrinsic pathway does not work in complete isolation.

4. Entry into the Common Pathway

• FXa combines with FVa (a cofactor), Ca2+, and phospholipids to form the prothrombinase complex.
• Prothrombinase cleaves prothrombin (FII) → thrombin (FIIa) - a massive, explosive amplification step.
• Thrombin cleaves fibrinopeptides A and B from fibrinogen → fibrin monomers, which polymerize into a soft clot.
• Factor XIIIa (activated by thrombin) cross-links fibrin strands via isopeptide bonds (Gln-Lys linkage), creating an insoluble, hard fibrin clot.

Regulation: Tissue Factor Pathway Inhibitor (TFPI)

1. TFPI binds FXa first (FXa-dependent activation of TFPI).
2. The TFPI-FXa complex then binds and inhibits TF-FVIIa, forming a quaternary inhibitory complex (TF-FVIIa-FXa-TFPI).

"The extrinsic pathway initiates clotting by the generation of FXa, and the intrinsic pathway amplifies and sustains clotting after the extrinsic pathway has been inhibited by TFPI." - Lippincott Illustrated Reviews: Biochemistry, 8e

Speed and Clinical Significance

• The extrinsic pathway is explosive in speed: with severe tissue trauma, clotting can occur in as little as 15 seconds.
• The intrinsic pathway, by contrast, requires 1-6 minutes.
• Speed is limited only by the amount of TF released and the available quantities of Factors X, VII, and V.

Lab Test: Prothrombin Time (PT / INR)

• PT measures the extrinsic + common pathway function (using thromboplastin to activate TF).
• Prolonged PT indicates deficiency in Factors VII, X, V, II (prothrombin), or fibrinogen.
• PT is the test monitored for warfarin therapy (warfarin inhibits vitamin K-dependent γ-carboxylation of Factors VII, IX, X, and II).

Thrombin's Central Amplifying Role

• Common pathway: Activates FV, fibrinogen (FI), FXIII
• Intrinsic pathway: Activates FXI, FVIII
• Extrinsic pathway: Activates FVII

Summary Table

• Miller's Anesthesia, 10e, Chapter 46
• Lippincott Illustrated Reviews: Biochemistry, 8e, Chapter 35
• Guyton and Hall Textbook of Medical Physiology (Guyton & Hall), Chapter 37